|Year : 2022 | Volume
| Issue : 6 | Page : 877-880
Appraisal of cytohistomorphology of papillary carcinoma thyroid and its variants with evaluation of discrepant cases
Supreetha Megalamane, Hemalatha Anatharamiah, CS B. R. Prasad
Department of Pathology, Sri Devaraj Urs Medical College, Kolar, Karnataka, India
|Date of Submission||04-Sep-2020|
|Date of Decision||19-Jul-2021|
|Date of Acceptance||10-Oct-2021|
|Date of Web Publication||11-Mar-2022|
Dr. Hemalatha Anatharamiah
Department of Pathology, Sri Devaraj Urs Medical College, Tamaka, Kolar, Karnataka
Source of Support: None, Conflict of Interest: None
Background: Papillary carcinoma thyroid is the most commonly occurring thyroid neoplasm which can be diagnosed by its characteristic cytological features by fine-needle aspiration procedure. Due too few limitations in fine-needle aspiration cytology (FNAC) technique, there are false-positive and false-negative diagnoses in papillary carcinoma thyroid lesions. Aim: In our study, we would like to evaluate the accuracy of thyroid FNAC and to determine the reasons for cytopathological discrepancies. Materials and Methods: Two hundred and twenty-three cases were collected from archives of our Department of Pathology. Slides were retrieved for which cytohistopathology correlation differed and reviewed. Statistical analysis for False positive/ negative rates, positive predictive value, sensitivity and specificity were done. Results: For 170 cases, cytohistopathology correlation, 27 cases were discordant which accounted for 15.2% of false-negative rates. 87% sensitivity, 96.6% positive predictive value and 10.6% false positive were calculated. Conclusion: FNAC is a reliable screening procedure in spite of having few pitfalls. Awareness of these pitfalls, while reporting by cytopathologist can minimize false-positive and false-negative reporting on thyroid lesions.
Keywords: Cytology, false-negative rate, false-positive rate, papillary thyroid carcinoma
|How to cite this article:|
Megalamane S, Anatharamiah H, B. R. Prasad C S. Appraisal of cytohistomorphology of papillary carcinoma thyroid and its variants with evaluation of discrepant cases. Med J DY Patil Vidyapeeth 2022;15:877-80
|How to cite this URL:|
Megalamane S, Anatharamiah H, B. R. Prasad C S. Appraisal of cytohistomorphology of papillary carcinoma thyroid and its variants with evaluation of discrepant cases. Med J DY Patil Vidyapeeth [serial online] 2022 [cited 2023 Jan 30];15:877-80. Available from: https://www.mjdrdypv.org/text.asp?2022/15/6/877/339386
| Introduction|| |
Thyroid cancer is the most common endocrine tumors in worldwide. Papillary thyroid carcinoma (PTC) is the most common histological type of malignant thyroid tumors. At presently, its incidence has being increasing, which is accounted for early detection by ultrasonography and fine-needle aspiration cytology (FNAC) technique.
FNAC is the first line of diagnostic test for evaluating the all thyroid gland lesions. This technique is an efficient method of segregating patients who needs surgical intervention owing its simplicity, cost-effectiveness, and easily available with high sensitivity and specificity.
There are well-established diagnostic criteria of PTC on FNAC and on histopathology. Despite of these advantages of FNAC and diagnostic criteria of PTC, FNAC can be limited by the quality of material. There are few worrisome possibilities of false-positive and false-negative results on cytology, which can have negative impact on patient care. The most common reasons for false positive results were because of the presence of similar features in various benign lesions of thyroid gland and the false-negative results were due to cases presenting with the absence of characteristic criteria of PTC or seen less frequently in cytology smears.,
Thus, in this study, we would like to evaluate the accuracy of thyroid FNAC and to determine the reasons for cytopathological discrepancies. We like to evaluate all the discordant cases and attempt will be made to minimize false-positive and false-negative diagnoses in PCT on FNAC.
| Materials and Methods|| |
For our study, we collected samples from 2014 to 2019 from archives of Department of Pathology from our college. After obtaining Institutional Ethical Committee permission from our institution, the data were searched from cytology and histopathology records. All the cases reported as PTC either on cytology or histopathology was documented. The information about the age and sex of the patient, and cytology and histopathology diagnoses so as to study the age distribution of the tumor and correlation between the cytology and histopathology reports (HPR). Cases which did not correlate slides were retrieved and reviewed by two pathologists to look for cause of misdiagnosis.
Statistical analysis was done using SPSS software version 22 (IBM, Chicago, USA). Sensitivity, specificity, positive predictive value, false positive rate, and false negative rate were analyzed.
| Results|| |
In our study, there were 223 cases reported as PTC on cytology or histopathology. The cytological diagnosis of PTC was given in 194 cases, out of which proper diagnosis of PCT in 146 cases and suspicious of papillary carcinoma thyroid in 48 cases.
The histopathology diagnosis of PTC was given in 188 cases; cytohistopathological correlation was among 170 cases. In 27 cases, the cytology reports differed. This amounted to false-negative rate of 15.2%.
Cytohistopathological correlation [Table 1] was 80%. False–positive rate was 10.6% [Table 2] and false-negative rate was 15.2% [Table 3]. Sensitivity was 87% and positive predictive value was 96.6%. The peak age was 26–45 years and female (164 cases) to be predominant than male (59 cases).
| Discussion|| |
Thyroid diseases are among the most common endocrine disorders worldwide. The National Cancer Registry Programme in India has reported thyroid as the most common site of cancer accounting for 1.5% of all cancers in men and 3.3% in women.
Papillary carcinoma is the frequent type of all thyroid malignancy diagnosed usually at third to fifth decades of life. In our study, second to fourth decades range with female preponderance 73.5% commonly seen.
Fine-needle aspiration of thyroid has gained popularity for initial diagnosis, since it is simple technique with reliable and time saving and cost effective. FNAC is regarded as Gold Standard since it is minimally invasive and can be done on outpatient basis. On cytology we can distinguish benign from neoplastic thyroid lesions, since FNAC has high diagnostic accuracy which has in turn reduced the incidence of surgical interventions.,
In spite of its advantageous properties, there exist certain limitations such as sample inadequacy, sampling techniques, worrisome histological alterations following fine-needle aspiration of the thyroid changes, false negative and false positive reports. Aware of these limitations will help the cytopathologist to reduce the errors while reporting.
In the present study, cytohistopathological correlation was seen in 170 cases out of 225 cases. On cytology, “Suspicious for papillary carcinoma” diagnosis was made for 48 cases. Out of which, 26 cases confirmed as PTC on histopathology and 4 cases as well-differentiated carcinoma. The rest 19 cytology diagnosis did not correlate with HPR. On histopathology, four cases were Hashimoto's thyroiditis, five cases nodular colloid goiter with micro papillary carcinoma, one case of nodular colloid goiter with secondary changes, eight cases of follicular adenoma, and one case of mixed adenoma. In this study, only PTC cases were selected; hence, there were no true negative cases and we could not calculate false positive rate, specificity, and negative predictive value. Thus, false-positive percentage of cytodiagnosis in our study was 10.6% as compared to other studies which ranged from 5.26% to 11.6%.,,,
This can be explained that pitfalls of FNACs in rendering confirmation of diagnosis in cases where there is a scarcity of characteristic features of PTC such as nuclear grooves, nuclear pseudoinclusions, and other features, which were less frequently seen in benign conditions of thyroid gland lesions such as Hashimoto's thyroiditis, adenomatous goiter, nodular colloid goiter, and follicular neoplasm. We observed same reasons of false-positive cases.,, Many other studies have mentioned that these features in benign conditions are very less common to occur when compared to PTC.,,,, Thus, the presence of characteristic features of PTC in these cases we reported them under “suspicious for papillary carcinoma.” However, these 18 cases showed nuclear grooves in ten0 cases, eight cases showed intranuclear cytoplasmic inclusions in less number of cells, and these cases did not demonstrate psammoma bodies, metaplastic cytoplasm, or three dimensional fragments of PTC features. Awareness of cytopathologist about pitfalls of FNACs and strict adherence to adequacy criteria can reduce the false-positive rates.
Representative area sampling error or sample misinterpretation of cytology can lead to false-negative FNAC results. These reasons can account to miss a malignant lesion on cytology and are consider being gray zone of FNAC.,,
In the present study, 27 cases with a diagnosis of PCT on HPE had been misinterpreted on cytology. False-negative rate in our study was 15.2% as compared to 4%–19% reported in other comparable research studies. False negative 9 cases of Hashimoto s thyroiditis on cytology found to be micropapillary carcinoma with Hashimoto's thyroiditis in six cases and PCT along with Hashimoto's thyroiditis in three cases. The word “micropapillary carcinoma” is an incidental findings, when tumor measuring <1 cm in diameter. Micropapillary carcinoma arising in Hashimoto's thyroiditis or PCT in Hashimoto's thyroiditis or in any other benign lesions has high chances of being missed on FNAC because FNAC is a blind technique, thus representative area sampling error can be frequently encountered.,
Diagnostically challenge in everyday practice to distinguish atypical nuclear changes that can be mistaken for foci of PTC for Hashimoto's thyroiditis diagnosis on cytology. Neoplasia incidence of diagnosis in setting of Hashimoto's thyroiditis by FNAC is 4%. The nuclei of thyroid follicular cells which are associated with lymphocytic infiltrates in Hashimoto's thyroiditis may show clearing of the nuclear chromatin and grooves which can be mistaken for PTC diagnosis. Thus, sampling errors on cytology are mainly because of false-negative diagnosis of Hashimoto's thyroiditis.
In our study, six cases diagnosis as follicular neoplasia on cytology were confirmed on HPE as FVPTC. Characteristic nuclear features are very much necessary for the diagnosis of PTC which is infrequently seen on cytology smears for diagnosing FVPTC cases. It is difficult to diagnose on cytologically since nuclear features of PTC are seen in only few cells. Other studies have reported that sensitivity of FNA in diagnosis of FVPTC is low and requires cytopathologist to consider infrequent nuclear features with follicular patter in cytology to consider the diagnosis of FVPTC, which is a major pitfall on cytology.,,
False-negative FNAC diagnosis can also occur due to inadequate sampling or due to the cystic fluid aspiration of the thyroid gland with underlying malignancy, which can be seen in our three cases. PTC is known thyroid carcinoma to undergo remarkable degenerative changes. Sampling from these lesions will yield only sparse tumor cells which can result in false interpretation as benign cystic change. Hence, in such cases, surgical excision to rule out an underlying malignancy, advice by cytopathologist will led into timely surgery and halts the undue complications of PTC on patients.,,
In our study, we found that, in spite of limitations on FNAC, it is a reliable technique of screening thyroid nodules for PTC with sensitivity as 87% and a positive predictive value of 96.6%. Our results are comparable with other studies where sensitivity ranged as low as 55.3% and false negative as low as 44.7%.
| Conclusion|| |
FNAC is a gold standard procedure and an indispensable tool for early diagnosis of all thyroid malignancies. Limitations of FNACs have led to false positive and false-negative diagnosis, especially in PTC thyroid. False-positive diagnosis can be reported due to the presence of characteristic features of PTC in benign conditions of thyroid gland. False-negative diagnosis has resulted due to inadequate sampling material like in cystic fluid or inadequate sampling area like in micropapillary carcinoma of thyroid and in cases with coexisting with Hashimoto's thyroiditis cases and infrequent nuclear features of PTC, which can cause diagnostic dilemma such as in FVPTC.
Hence, awareness of various pitfalls of FNAC of thyroid lesions by cytopathologist can limit false-positive and false-negative diagnosis, which in turn would aid in choosing appropriate treatment modality and better patient care.
Financial support and sponsorship
Conflicts of interest
There are no conflicts of interest.
| References|| |
LiVolsi VA. Papillary thyroid carcinoma: An update. Mod Pathol 2011;24 Suppl 2:S1-9.
Sharma C. An analysis of trends of incidence and cytohistological correlation of papillary carcinoma of the thyroid gland with evaluation of discordant cases. J Cytol 2016;33:192-8.
] [Full text]
Jain A, Alam K, Maheshwari V, Rabindranath D, Khan AA, Khan R. Cytological features in the early diagnosis of papillary carcinoma of thyroid in clinically inapparent cases. Ann Pathol Lab Med 2015;02:A93-A97.
Kumar S, Singh N, Siddaraju N. “Cellular swirls” and similar structures on fine needle aspiration cytology as diagnostic clues to papillary thyroid carcinoma: A report of 4 cases. Acta Cytol 2010;54:939-42.
Epstein EJ, Chao J, Keller C, Cajigas A. Infarcted papillary thyroid cancer after fine needle aspiration biopsy. Endocrine 2011;40:322-3.
Jang EK, Song DE, Gong G, Baek JH, Choi YM, Jeon MJ, et al.
Positive cytology findings and a negative histological diagnosis of papillary thyroid carcinoma in the thyroid: is it a false-positive cytology or a disappearing tumor? Eur Thyroid J 2013;2:203-10.
Zhang Y, Fraser JL, Wang HH. Morphologic predictors of papillary carcinoma on fine-needle aspiration of thyroid with ThinPrep preparations. Diagn Cytopathol 2001;24:378-83.
Clark JR, Eski SJ, Freeman JL. Risk of malignancy in Filipinos with thyroid nodules – A matched pair analysis. Head Neck 2006;28:427-31.
Cheung CC, Ezzat S, Freeman JL, Rosen IB, Asa SL. Immunohistochemical diagnosis of papillary thyroid carcinoma. Mod Pathol 2001;14:338-42.
Lerma E, Mora J; Thyroid Study Group. Telomerase activity in “suspicious” thyroid cytology. Cancer 2005;105:492-7.
Finley DJ, Arora N, Zhu B, Gallagher L, Fahey TJ 3rd
. Molecular profiling distinguishes papillary carcinoma from benign thyroid nodules. J Clin Endocrinol Metab 2004;89:3214-23.
Weber F, Shen L, Aldred MA, Morrison CD, Frilling A, Saji M, et al.
Genetic classification of benign and malignant thyroid follicular neoplasia based on a three-gene combination. J Clin Endocrinol Metab 2005;90:2512-21.
Anand A, Singh KR, Kushwaha JK, Hussain N, Sonkar AA. Papillary Thyroid Cancer and Hashimoto's Thyroiditis: An Association Less Understood. Indian J Surg Oncol 2014;5:199-204.
Batistatou A, Scopa CD. Pathogenesis and diagnostic significance of nuclear grooves in thyroid and other sites. Int J Surg Pathol 2009;17:107-11.
Bradley NL, Wiseman SM. Papillary thyroid microcarcinoma: The significance of high risk features. BMC Cancer 2017;17:142.
Gao R, Jia X, Liang Y, Fan K, Wang X, Wang Y, et al.
Papillary thyroid micro carcinoma: The incidence of high-risk features and its prognostic implications. Front Endocrinol (Lausanne) 2019;10:1-8.
Baloch ZW, LiVolsi VA. Cytologic and architectural mimics of papillary thyroid carcinoma. Diagnostic challenges in fine-needle aspiration and surgical pathology specimens. Am J Clin Pathol 2006;125 Suppl: S135-44.
Kanth KG, Satyanarayana V. Preoperative diagnosis of follicular variant of papillary carcinoma of thyroid – A retrospective study. Indian J Pathol Oncol 2016;3:392-6.
Baloch ZW, Gupta PK, Yu GH, Sack MJ, LiVolsi VA. Follicular variant of papillary carcinoma. Cytologic and histologic correlation. Am J Clin Pathol 1999;111:216-22.
Kim WB. A closer look at papillary thyroid carcinoma. Endocrinol Metab (Seoul) 2015;30:1-6.
Gonzalez RG, Molina RB, Burciaga RG, Gastelum MG, Frechero NM, Rodriguez SS. Papillary thyroid carcinoma: Differential diagnosis and prognostic values of its different variants: Review of the Literature. Int Sch Res Netw 2011;2:1-9.
Rao R, Giriyan SS, Rangappa PK. Clinicopathological profile of papillary carcinoma of thyroid: A 10 year experience in a tertiary care institute in North Karnataka, India. Indian J Cancer 2017;54:514-8.
] [Full text]
[Table 1], [Table 2], [Table 3]